Croda has announced its acquisition of research enterprise Enza Biotech. Terms of the deal were not disclosed.

The Lund University spin-off was founded in 2012 to develop a next generation of renewable surfactants. The acquisition will enhance Croda’s natural and renewable product portfolio, with Co-Founders Maria Andersson and Stefan Ulvenlund leading the commercialization of the sustainable ingredients.

“Enza Biotech offers a fantastic opportunity for us to fill an identified technology gap in the surfactants market using natural and renewable raw materials. It is a great fit as sustainability underpins our growth strategy and is an area that already sets us apart in the eyes of our customers,” said Steve Foots, Croda CEO.